You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Structural heart defects

Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems)

  • Diagnostics guidance
  • Reference number: DG13
  • Published:  20 August 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technologies
  • 3 Clinical need and practice
  • 4 The diagnostic tests
  • 5 Outcomes
  • 6 Considerations
  • 7 Recommendations for further research
  • 8 Implementation
  • 9 Diagnostics advisory committee members and NICE project team
  • 10 Sources of evidence considered by the committee

2 The technologies

2.1

Three viscoelastometric point‑of‑care testing devices (ROTEM, TEG and Sonoclot systems) used to help detect, manage and monitor haemostasis were included in this assessment. Additional details of the ROTEM, TEG and Sonoclot devices are provided in section 4.


Next page 3 Clinical need and practice Previous page 1 Recommendations
Back to top